Co-Diagnostics, Inc. Common Stock (CODX) Live Share Price, Invest From India

Co-Diagnostics, Inc. Common Stock Stock Performance

as on April 16, 2026 at 6:57 am IST

Day's Low
Day's High
$1.38
Day's Price Range
$1.45
$1.43
3.50%
Downside
1.40%
Upside
52 Week's Low
52 Week's High
$1.35
52-Week Price Range
$46.50
$1.43
5.59%
Downside
3151.75%
Upside

Co-Diagnostics, Inc. Common Stock share price movements today

Previous Close: $1.38
Open: $1.42
Volume: 455.5K
Day's Low - High: $1.38 - $1.45
52 Week Low - High: $1.35 - $46.50

Co-Diagnostics, Inc. Common Stock Historical Returns

1 Month Return: -43.2 %
3 Month Return: -49.82 %
1 Year Return: -85.95 %
3 Year Return: -96.97 %
5 Year Return: -99.47 %

Co-Diagnostics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Co-Diagnostics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.0M

EPS (TTM)

-12.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.31%

PE Ratio (TTM)

PEG Ratio

EBITDA

-30.2M

Revenue (TTM)

622.5K

Profit Margin

0.00%

Return On Equity TTM

-125.89%

Co-Diagnostics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Co-Diagnostics, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Co-Diagnostics, Inc. Common Stock	SELL	$5.0M	-99.47%	NA	0.00%
Boston Scientific Corp	BUY	$96.0B	57.93%	33.3	14.44%
Stryker Corporation	BUY	$130.7B	32.71%	40.67	12.92%
Medtronic PLC	BUY	$111.8B	-30.82%	24.33	13.00%
Abbott Laboratories	BUY	$176.5B	-18.33%	27.16	14.72%

See all

Stock Returns calculator for Co-Diagnostics, Inc. Common Stock Stock including INR - Dollar returns

The Co-Diagnostics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Co-Diagnostics, Inc. Common Stock investment value today

Current value as on today

₹15,420

Returns

-₹84,580

(-84.58%)

Returns from Co-Diagnostics, Inc. Common Stock Stock

-₹85,856 (-85.86%)

Dollar Impact

₹1,275 (+1.28%)

Analyst Recommendation on Co-Diagnostics, Inc. Common Stock Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Co-Diagnostics, Inc. Common Stock. Average target price of $45

Co-Diagnostics, Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on Co-Diagnostics, Inc. Common Stock.

What analysts predicted

96.82%UPSIDE

Target Price

$45

Current Price

$1.43

Analyzed by

6 Analysts

Target

$45.00

Co-Diagnostics, Inc. Common Stock target price $45, a slight upside of 96.82% compared to current price of $1.43. According to 6 analysts rating.

Co-Diagnostics, Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for Co-Diagnostics, Inc. Common Stock Stock has increased by 4725% in the last 30 days, reflecting an upward trend in search activity.

Time period: March 17, 2026 to April 16, 2026

Change:4725% versus previous 30 day period

Co-Diagnostics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	2	3	0	2	0	0	0	0	0	0
Gross Profit	2	0	0	2	0	0	0	0	0	-1
Operating Income	-8	-11	-10	-7	-10	-11	-8	-8	-7	-7
EBITDA	-8	-11	-9	-7	-9	-11	-8	-7	-6	-7
Interest Expense	-	3	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-10	-9	-7	-9	-11	-7	-7	-7	-26
Income Tax Expense	-2	3	0	0	0	0	0	0	-1	0
Net Income	-5	-14	-9	-7	-9	-11	-7	-7	-5	-25
Net Profit Margin	-243.47%	-412.82%	-3684.36%	-286.03%	-1512.37%	-7387.37%	-14983.53%	-4745.02%	-4049.27%	-43170.00%

Co-Diagnostics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	0	0	74	97	34	6	3	0
Gross Profit	0	0	0	0	57	86	28	2	2	0
Operating Income	-1	-4	-6	-5	41	46	-26	-42	-40	-31
EBITDA	-1	-6	-6	-6	41	46	-10	-41	-38	-30
Interest Expense	0	0	0	0	0	0	14	-	-	-
Depreciation	-	0	0	0	0	0	1	1	1	1
Income Before Tax	-1	-6	-6	-6	42	45	-18	-38	-37	-48
Income Tax Expense	-	0	0	0	0	8	-4	-2	0	-1
Net Income	-1	-6	-6	-6	42	36	-14	-35	-37	-46
Net Profit Margin	0.00%	-90827.88%	-15714.27%	-2882.00%	56.98%	37.45%	-41.61%	-518.68%	-961.37%	-11213.62%

Co-Diagnostics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-14	-9	-7	-9	-11	-7	-7	-5	-25
Operating Cash Flow	-4	-8	-5	-7	-8	-8	-8	-5	-6
Investing Cash Flow	9	16	-4	4	0	7	17	2	0
Financing Cash Flow	0	-	-	-	0	0	0	4	6
Change in Cash	4	8	-9	-3	-7	-1	9	0	0

Co-Diagnostics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-6	-6	-6	42	36	-14	-35	-37	-46
Operating Cash Flow	-3	-4	-5	28	41	6	-22	-29	-29
Investing Cash Flow	0	0	0	-5	4	-58	15	17	26
Financing Cash Flow	5	1	5	19	0	-14	-1	0	11
Change in Cash	2	-2	0	42	45	-65	-8	-11	8

Global Institutional Holdings in Co-Diagnostics, Inc. Common Stock

Funds	Holdings
Geode Capital Management, LLC	0.42%
Triton Wealth Management, PLLC	0.03%
Virtu Financial LLC	0.07%
QRG Capital Management, Inc.	0.05%
BlackRock Inc	0.4%

See all

Co-Diagnostics, Inc. Common Stock News & Key Events

Insights on Co-Diagnostics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Co-Diagnostics Inc has experienced a drawdown of -97.1%, however Boston Scientific Corp. resisted the overall trend and outperformed by 89.8%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 9.8% return, outperforming this stock by 96.2%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 162.91K → 59.63K (in $), with an average decrease of 34.9% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -5.88M → -25.74M (in $), with an average decrease of 337.3% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, CODX stock has moved down by -4.2%

About Co-Diagnostics, Inc. Common Stock

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

Organisation	Co-Diagnostics, Inc. Common Stock
Headquarters	2401 S. Foothill Dr., Salt Lake City, UT, United States, 84109
Industry	Medical Devices
CEO	Mr. Dwight H. Egan
E-voting on shares	Click here to vote

Key Management of Co-Diagnostics, Inc. Common Stock

Name	Title
Dr. Mayuranki Almaula Ph.D.	Senior Vice President of Overseas Operations & Strategic Alliances
Mr. Seth Egan	Chief Commercialization Officer
Mr. Dwight H. Egan	Chairman, CEO & President
Mr. Richard David Abbott	President
Mr. David Nielsen	Chief Operating Officer
Mr. Christopher Thurston	Chief Technology Officer
Mr. Andrew Benson	Head of Investor Relations

FAQs

What is Co-Diagnostics, Inc. Common Stock share price today?

Co-Diagnostics, Inc. Common Stock share price today is $1.43 as on April 16, 2026 at 1:27 am IST at the close of the market. Co-Diagnostics, Inc. Common Stock share today touched a day high of $1.45 and a low of $1.38.

What is the 52 week high and 52 week low for Co-Diagnostics, Inc. Common Stock share?

Co-Diagnostics, Inc. Common Stock share touched a 52 week high of $46.5 on October 27, 2025 and a 52 week low of $1.35 on April 9, 2026. Co-Diagnostics, Inc. Common Stock stock price today i.e. April 16, 2026 at 1:27 am IST is closed at $1.43,which is 96.92% down from its 52 week high and 5.93% up from its 52 week low.

What is Co-Diagnostics, Inc. Common Stock's market capitalisation today?

Co-Diagnostics, Inc. Common Stock market capitalisation is $0.00T as on April 16, 2026 at 1:27 am IST.

How to invest in Co-Diagnostics, Inc. Common Stock Stock (CODX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Co-Diagnostics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Co-Diagnostics, Inc. Common Stock Shares that will get you 1.0490 shares as per Co-Diagnostics, Inc. Common Stock share price of $1.43 per share as on April 16, 2026 at 1:27 am IST.

What is the minimum amount required to buy Co-Diagnostics, Inc. Common Stock Stock (CODX) from India?

Indian investors can start investing in Co-Diagnostics, Inc. Common Stock (CODX) shares with as little as ₹93.436 or $1 (as of April 16, 2026 at 1:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹934.36 in Co-Diagnostics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on April 16, 2026 at 1:41 pm IST). Based on Co-Diagnostics, Inc. Common Stock share’s latest price of $1.43 as on April 16, 2026 at 1:27 am IST, you will get 6.9930 shares of Co-Diagnostics, Inc. Common Stock. Learn more about fractional shares .

What are the returns that Co-Diagnostics, Inc. Common Stock has given to Indian investors in the last 5 years?

Co-Diagnostics, Inc. Common Stock stock has given -99.47% share price returns and 24.76% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?